nach oben

Breast Cancer Research and Treatment

Erschienen in:

01.02.2020 | Letter to the Editor

Proper treatment of breast angiosarcoma-mastectomy or breast conserving surgery?

verfasst von: Darko Zdravkovic, Miroslav Granic, Bogdan Crnokrak

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Excerpt

We have read with great interest the article “Primary and secondary breast angiosarcoma: single center report and a meta-analysis” published by Abdou et al. [1]. Firstly, we would like to congratulate the authors on this comprehensive article and huge experience. However, we would like to comment some facts concerning the surgical treatment of breast angiosarcoma. …

Abdou Y, Elkhanany A, Attwood K, Ji W, Takabe K, Opyrchal M (2019) Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast Cancer Res Treat 178(3):523–533CrossRef

Taffurelli M, Pellegrini A, Meattini I et al (2019) Secondary breast angiosarcoma: a multicentre retrospective survey by the National Italian Association of Breast Surgeons (ANISC). Breast 45:56–60CrossRef

McClelland S III, Hatfield J, Degnin C, Chen Y, Mitin T (2019) Extent of resection and role of adjuvant treatment in resected localized breast angiosarcoma. Breast Cancer Res Treat 175(2):409–418CrossRef

Titel: Proper treatment of breast angiosarcoma-mastectomy or breast conserving surgery?
verfasst von: Darko Zdravkovic
Miroslav Granic
Bogdan Crnokrak
Publikationsdatum: 01.02.2020
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-019-05509-0

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Proper treatment of breast angiosarcoma-mastectomy or breast conserving surgery?

Excerpt

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Pre- and post-diagnostic intake of whole grain and dairy products and breast cancer prognosis: the Danish Diet, Cancer and Health cohort

Paget’s disease of the nipple in a Her2-positive breast cancer xenograft model

Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously

Breast density measured volumetrically in a clinical environment: cross-sectional study with photon counting technology

Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions

Tumor microenvironment and breast cancer survival: combined effects of breast fat, M2 macrophages and hyaluronan create a dismal prognosis

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie